OnKure Therapeutics (OKUR) Live Share Price, Invest From India

OnKure Therapeutics Stock Performance

as on October 12, 2026 at 2:15 pm IST

Day's Low
Day's High
$2.23
Day's Price Range
$2.42
$2.41
7.47%
Downside
0.41%
Upside
52 Week's Low
52 Week's High
$2.13
52-Week Price Range
$5.38
$2.41
11.62%
Downside
123.24%
Upside

OnKure Therapeutics share price movements today

Previous Close: $2.30
Open: $2.29
Volume: 1.1M
Market Cap: $97.6M
Day's Low - High: $2.23 - $2.42
52 Week Low - High: $2.13 - $5.38

OnKure Therapeutics Historical Returns

1 Month Return: -22.26 %
3 Month Return: -43.69 %
1 Year Return: -20.98 %
3 Year Return: 0 %
5 Year Return: 0 %

OnKure Therapeutics Stock Fundamentals & Key Indicators

Check OnKure Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$97.6M

EPS (TTM)

-3.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.69

Industry PE ratio

-3.05

PEG Ratio

-0.02

EBITDA

-57.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-49.02%

OnKure Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OnKure Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
OnKure Therapeutics	StrongBuy	$97.6M	NA	-0.69	0.00%	0.00%
Moderna	Neutral	$89.8B	-27.68%	-28.20	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$129.3B	183.05%	29.45	86.04%	0.00%
Regeneron	Buy	$76.9B	37.12%	17.83	84.86%	0.50%

Stock Returns calculator for OnKure Therapeutics Stock including INR - Dollar returns

The OnKure Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

OnKure Therapeutics investment value today

Current value as on today

₹85,339

Returns

-₹14,661

(-14.66%)

Returns from OnKure Therapeutics Stock

-₹20,984 (-20.98%)

Dollar Impact

₹6,323 (+6.32%)

Analyst Recommendation on OnKure Therapeutics Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for OnKure Therapeutics. Average target price of $17

OnKure Therapeutics Share Price Target

Get share price movements and forecasts by analysts on OnKure Therapeutics.

Current Price

$2.41

Analyzed by

4 Analysts

High

$21

Low

$14

OnKure Therapeutics target price $0, a slight upside of 0% compared to current price of $2.41. According to 4 analysts rating.

Indian Investors' Interest in OnKure Therapeutics Stock

Search interest for OnKure Therapeutics Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 12, 2026 to October 12, 2026

Change:-25% versus previous 30 day period

OnKure Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	0	0	-	-	-	-	0	-
Operating Income	-9	-14	-4	-33	-17	-16	-15	-14	-15	-16
EBITDA	-9	-13	-3	-31	-15	-15	-14	-13	-14	-15
Interest Expense	-	0	-	-	-	-	0	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-14	-3	-35	-15	-15	-14	-13	-15	-15
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-9	-14	-3	-35	-15	-15	-14	-13	-15	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OnKure Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	-	-	-	0
Operating Income	-19	-39	-29	-36	-54	-62
EBITDA	-19	-39	-29	-34	-51	-58
Interest Expense	-	-	-	-	0	-
Depreciation	0	0	0	0	0	0
Income Before Tax	-19	-39	-29	-35	-52	-59
Income Tax Expense	-	-	-	-	-	-
Net Income	-19	-39	-29	-35	-52	-59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OnKure Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-9	-14	-11	-35	-15	-15	-14	-13	-15	-15
Operating Cash Flow	-10	-6	-10	-21	-14	-13	-13	-11	-12	-10
Investing Cash Flow	0	0	0	-45	0	0	0	0	0	-9
Financing Cash Flow	0	5	0	114	0	-	-	0	145	-5
Change in Cash	-10	0	-10	50	-14	-13	-13	-11	133	-25

OnKure Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-19	-39	-29	-35	-52	-59
Operating Cash Flow	-18	-37	-26	-34	-51	-51
Investing Cash Flow	7	-23	-1	0	15	0
Financing Cash Flow	47	132	26	53	116	0
Change in Cash	36	71	-1	18	80	-51

Global Institutional Holdings in OnKure Therapeutics

Check out the Institutions with significant holdings in OnKure Therapeutics.

Funds	Holdings
Peter Kolchinsky	9.87%
Vanguard	4.05%
iShares	2.20%
VANGUARD INDEX FUNDS	1.44%
Scott Kapnick	1.34%

See all

Insights on OnKure Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 123.3% return, outperforming this stock by 220.0%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 759.6%
NEGATIVE IMPACT
Price Dip
In the last 3 months, OKUR stock has moved down by -43.7%

About OnKure Therapeutics

OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.

Organisation	OnKure Therapeutics
Headquarters	6707 Winchester Circle, Boulder, CO, 80301, US
Industry	Biotechnology
CEO	Nicholas A. Saccomano

Key Management of OnKure Therapeutics

Name	Title
Dr. Nicholas A. Saccomano Ph.D.	President, CEO & Director
Dr. Isaac Manke Ph.D.	Senior VP of Business Development & Director
Dr. Dylan Hartley Ph.D.	Chief Scientific Officer
Mr. Rogan P. Nunn J.D.	General Counsel & Secretary
Dr. James Blake Ph.D.	Senior Vice President of Computational Drug Discovery
Dr. Mark L. Boys Ph.D.	Senior Vice President of Discovery Chemistry
Mr. Jason A. Leverone CPA	Chief Financial Officer
Dr. Samuel Agresta M.D., M.P.H.	Chief Medical Officer
Dr. Kevin S. Litwiler Ph.D.	Senior Vice President of DMPK & Clinical Pharmacology
Ms. Roberta Alton	Senior Vice President of Clinical Operations

FAQs

What is OnKure Therapeutics share price today?

OnKure Therapeutics share price today is $2.41 as on October 12, 2026 at 8:45 am IST at the close of the market. OnKure Therapeutics share today touched a day high of $2.42 and a low of $2.23.

What is the 52 week high and 52 week low for OnKure Therapeutics share?

OnKure Therapeutics share touched a 52 week high of $5.38 on May 1, 2026 and a 52 week low of $2.13 on October 8, 2026. OnKure Therapeutics stock price today i.e. October 12, 2026 at 8:45 am IST is closed at $2.41,which is 55.20% down from its 52 week high and 13.15% up from its 52 week low.

What is OnKure Therapeutics's market capitalisation today?

OnKure Therapeutics market capitalisation is $0.00T as on October 12, 2026 at 8:45 am IST.

How to invest in OnKure Therapeutics Stock (OKUR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for OnKure Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy OnKure Therapeutics Stock (OKUR) from India?

Indian investors can start investing in OnKure Therapeutics (OKUR) shares with as little as ₹95.76000213623047 or $1 (as of October 12, 2026 at 6:48 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in OnKure Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 12, 2026 at 6:48 pm IST). Based on OnKure Therapeutics share’s latest price of $2.41 as on October 12, 2026 at 8:45 am IST, you will get 4.1494 shares of OnKure Therapeutics. Learn more about fractional shares .